Thrombospondin-4 mediates cardiovascular remodelling in angiotensin II-induced hypertension.

[1]  M. Ritelli,et al.  Transcriptome analysis of skin fibroblasts with dominant negative COL3A1 mutations provides molecular insights into the etiopathology of vascular Ehlers-Danlos syndrome , 2018, PloS one.

[2]  M. Stampanoni,et al.  Angiotensin II infusion into ApoE-/- mice: a model for aortic dissection rather than abdominal aortic aneurysm? , 2017, Cardiovascular research.

[3]  J D Humphrey,et al.  A hidden structural vulnerability in the thrombospondin-2 deficient aorta increases the propensity to intramural delamination. , 2017, Journal of the mechanical behavior of biomedical materials.

[4]  J. Golledge,et al.  High serum thrombospondin-1 concentration is associated with slower abdominal aortic aneurysm growth and deficiency of thrombospondin-1 promotes angiotensin II induced aortic aneurysm in mice. , 2017, Clinical science.

[5]  S. Milz,et al.  Tenomodulin is Required for Tendon Endurance Running and Collagen I Fibril Adaptation to Mechanical Load , 2017, EBioMedicine.

[6]  Xue-Hai Zhu,et al.  Experimental in vivo and ex vivo models for the study of human aortic dissection: promises and challenges. , 2016, American journal of translational research.

[7]  B. Uvelius,et al.  Assessing the contribution of thrombospondin-4 induction and ATF6α activation to endoplasmic reticulum expansion and phenotypic modulation in bladder outlet obstruction , 2016, Scientific Reports.

[8]  E. vanBavel,et al.  Thrombospondin-4 knockout in hypertension protects small artery endothelial 1 function but induces aortic aneurysms , 2016 .

[9]  G. Schett,et al.  Deficiency of Thrombospondin-4 in Mice Does Not Affect Skeletal Growth or Bone Mass Acquisition, but Causes a Transient Reduction of Articular Cartilage Thickness , 2015, PloS one.

[10]  P. Moerland,et al.  Gene Expression and MicroRNA Expression Analysis in Small Arteries of Spontaneously Hypertensive Rats. Evidence for ER Stress , 2015, PloS one.

[11]  S. Friedman,et al.  Modulation of cardiac fibrosis by Krüppel-like factor 6 through transcriptional control of thrombospondin 4 in cardiomyocytes. , 2015, Cardiovascular research.

[12]  B. Olde,et al.  Myocardin Family Members Drive Formation of Caveolae , 2015, PloS one.

[13]  J. Golledge,et al.  A Peptide Antagonist of Thrombospondin-1 Promotes Abdominal Aortic Aneurysm Progression in the Angiotensin II–Infused Apolipoprotein-E–Deficient Mouse , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[14]  J. Drazba,et al.  Control of organization and function of muscle and tendon by thrombospondin-4. , 2014, Matrix biology : journal of the International Society for Matrix Biology.

[15]  S. Tyagi,et al.  Angiotensin-II induced hypertension and renovascular remodelling in tissue inhibitor of metalloproteinase 2 knockout mice , 2013, Journal of hypertension.

[16]  Z. Popović,et al.  Thrombospondin‐4 regulates fibrosis and remodeling of the myocardium in response to pressure overload , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  D. Kass,et al.  Thrombospondin-4 Is Required for Stretch-Mediated Contractility Augmentation in Cardiac Muscle , 2011, Circulation research.

[18]  Y. Soini,et al.  Thrombospondin-4 expression is rapidly upregulated by cardiac overload. , 2008, Biochemical and biophysical research communications.

[19]  E. Topol,et al.  Thrombospondins, their polymorphisms, and cardiovascular disease. , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[20]  K. Chatila,et al.  The role of the thrombospondins in healing myocardial infarcts. , 2007, Cardiovascular & hematological agents in medicinal chemistry.

[21]  Phillip Ruiz,et al.  Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney , 2006, Proceedings of the National Academy of Sciences.

[22]  Remco Dijkman,et al.  Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  M. Entman,et al.  Critical Role of Endogenous Thrombospondin-1 in Preventing Expansion of Healing Myocardial Infarcts , 2005, Circulation.

[24]  J. Rysä,et al.  Distinct Upregulation of Extracellular Matrix Genes in Transition From Hypertrophy to Hypertensive Heart Failure , 2005, Hypertension.

[25]  M. Nieminen,et al.  Regression of Hypertensive Left Ventricular Hypertrophy by Losartan Compared With Atenolol: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Trial , 2004, Circulation.

[26]  Jane Fridlyand,et al.  Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis. , 2003, Cancer research.

[27]  R. Beuerman,et al.  Distribution of thrombospondin-4 in the bovine eye , 2003, Current eye research.

[28]  H. Brunner.  Experimental and clinical evidence that angiotensin II is an independent risk factor for cardiovascular disease. , 2001, The American journal of cardiology.

[29]  L. Lagae,et al.  Classical Ehlers-Danlos syndrome caused by a mutation in type I collagen. , 2000, American journal of human genetics.

[30]  L. Mazzolai,et al.  Increased cardiac angiotensin II levels induce right and left ventricular hypertrophy in normotensive mice. , 2000, Hypertension.

[31]  F. Reinholt,et al.  Fibromodulin-null Mice Have Abnormal Collagen Fibrils, Tissue Organization, and Altered Lumican Deposition in Tendon* , 1999, The Journal of Biological Chemistry.

[32]  K. Michalickova,et al.  Mutations of the alpha2(V) chain of type V collagen impair matrix assembly and produce ehlers-danlos syndrome type I. , 1998, Human molecular genetics.

[33]  P. Caroni,et al.  Thrombospondin-4, an extracellular matrix protein expressed in the developing and adult nervous system promotes neurite outgrowth , 1995, The Journal of cell biology.

[34]  H. Drexler,et al.  Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium. , 1994, Circulation research.